Epilepsia and paroxysmal conditions

Advanced search


Full Text:


The article touches upon major issues related to pregnancy in epilepsy using the authors’ own experience and results of 3 latest studies carried out by American researchers and analyzed with an evidence-based medicine approach.

About the Author

P. N. Vlasov
Moscow State University of Medicine and Dentistry
Russian Federation
Chair of Neurology, Faculty of Medicine


1. Власов П.Н. Эпилепсия у женщин: клинические, электрофизиологические, гормональные и терапевтические аспекты. Автореф. докт. дисс.- Мос.мед.академия им. И.М.Сеченова. 2001, 48 с.

2. Власов П.Н., Петрухин В.А., Наумова Г.И. Сопутствующая патология со стороны женской половой сферы и беременность при эпилепсии. Качественная клиническая практика, 2005. 3: 52-60.

3. Карлов В.А., Власов П.Н., Петрухин В.А., Краснопольский В.И. Терапевтическая тактика при эпилепсии во время беременности. Методические указания МЗ РФ N2001/130, 15 с.

4. Повереннова И.Е., Якунина А.В., Постнова Е.Н. и соавт. Эпилепсия и беременность. Журн. невропатол. и психиатр. Эпилепсия. Приложение к журналу 2008. 3: 41-47.

5. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry, 2004; 75: 1575–1583.

6. Artama M., Auvinen A., Raudaskoski T., Isojarvi I., Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology, 2005; 64: 1874–1878.

7. Betts T., Fox C. Proactive preconception counseling for women with epilepsy — is it effective? Seizure, 1999; 8: 322–327.

8. Choulika S., Grabowski E., Holmes L.B. Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol, 2004; 190: 882–883.

9. Gaily E., Kantola-Sorsa E., Hiilesmaa V., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology, 2004; 62: 28–32.

10. Gjerde I.O., Strandjord R.E., Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand, 1988; 78: 198–205.

11. Harden C.L., Hopp J., Ting T.Y., et al. Management issues for women with epilepsy— Focus on pregnancy (an evidencebased review): I. Obstetrical complications and change in seizure frequency : Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 2009; 50: 1229-1236.

12. Harden C.L., Meador K.J., Pennell P.B., et al. Management issues for women with epilepsy—Focus on pregnancy (an evidencebased review): II. Teratogenesis and perinatal outcomes : Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 2009; 50: 1237-1246.

13. Harden C.L., Pennell P.B., Koppel B.S., et al.Management issues for women with epilepsy—Focus on pregnancy (an evidencebased review): III. Vitamin K, folic acid, blood levels, and breast-feeding : Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 2009; 50: 1247-1255.

14. Hiilesmaa V.K., Bardy A., Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol, 1985; 152: 499–504.

15. Holmes L.B., Harvey E.A., Coull B.A., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med., 2001; 344: 1132–1138.

16. Holmes L.B., Rosenberger P.B., Harvey E.A., Khoshbin S., Ryan L. Intelligence and physical features of children of women with epilepsy. Teratology, 2000; 61: 196–202.

17. Hvas C.L., Henriksen T.B., Ostergaard J.R., Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. Br J Obstet Gynaecol, 2000; 107:896–902.

18. Kaaja E., Kaaja R., Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology, 2003; 60: 575–579.

19. Kaaja E., Kaaja R., Matila R., Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology, 2002; 58: 549–553.

20. Koch S., Titze K., Zimmermann R.B., et al. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia, 1999; 40: 1237–1243.

21. Kuhnz W., Koch S., Helge H., Nau H. Primidone and Phenobarbital during lactation period in epileptic women: total and free drug levels in the nursed infants and their effects on neonatal behavior. Dev Pharmacol Ther., 1988; 11: 147–154.

22. Losche G., Steinhausen H.C., Koch S., Helge H. The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr, 1994; 83: 961–966.

23. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: prospective study from the UK epilepsy and pregnancy register. J. Neurol. Neurosurg. Psychiatry. 2006; 77: 193-198.

24. Nau H., Rating D., Koch S., Hauser I., Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther, 1981; 219: 768–777.

25. Oyen N., Vollset S.E., Eide M.G., et al. Maternal epilepsy and offsprings’ adult intelligence: a population-based study from Norway. Epilepsia, 2007; 48: 1731–1738.

26. Pennell P.B., Peng L., Newport D.J., et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology, 2008; 70: 2130–2136.

27. Richmond J.R., Krishnamoorthy P., Andermann E., Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol, 2004; 190: 371–379.

28. Shorvon, S.D., Tomson T., Cock H.R. The management of epilepsy during pregnancy— Progress is painfully slow. Epilepsia, 2009; 50: 973–974.

29. Tomson T., Lindbom U., Ekqvist B., Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia, 1994; 35: 122–130.

30. Vanoverloop D., Schnell R.R., Harvey E.A., Holmes L.B. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol, 1992; 14: 329–335.

31. Viinikainen K., Heinonen S., Eriksson K., Kalviainen R. Community- based, prospective, controlled study of obstetric and neonatal outcomes of 179 pregnancies in women with epilepsy. Epilepsia, 2006; 47: 186–192.

32. Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr, 2004; 93: 1774–1776.

For citation:

Vlasov P.N. PREGNANCY IN EPILEPSY: AN EVIDENCE-BASED MEDICINE APPROACH. Epilepsia and paroxysmal conditions. 2009;1(1):8-13. (In Russ.)

Views: 36

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)